Clinical Trial Update: Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma [Phase 1]

View source ↗

Summary

This update describes a Phase 1 trial of gefitinib plus temozolomide in patients with malignant primary glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Gefitinib (Gefitinib)
• Temodar (Temozolomide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED